ESC hot line ACCOAST was halted; bleeds, no benefit with earlier prasugrel

A slide set from a French Cardiology Society presentation in Paris this past January is one of the only online mentions that anything had gone awry with this study, which was testing use of prasugrel at the time of PCI vs pretreatment at the time of diagnosis in patients with non-STEMI.

Source: theHeart.org - August 28, 2013 Category: Cardiology Source Type: news